PHOTONIC PHARMA, LLC

Biotech · Private

Fluorescent protein biosensors and high-throughput screening platform using time-resolved fluorescence lifetime detection for drug discovery

Grants
$1.4M
3 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Fluorescence lifetime platform to discover small-molecule inhibitors of tau and alpha-synuclein oligomerization.$593,889
Federal grantDepartment of Health and Human Services · Phase I · Drug Discovery Pipeline Targeting Pathologically Leaky Calcium Release Channels in Age-Related Indications$499,443
Federal grantDepartment of Health and Human Services · Phase I · High-throughput discovery platform for modulators of cardiac muscle proteins to treat heart failure$306,471
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1406DD Therapeutics, LLC——
1407Bedrock Therapeutics, Inc.——
1408Integrated Protein Technologies, Inc.——
1409PHOTONIC PHARMA, LLC——
1410GIGAMUNE, INC.——
1411Complex Computation, LLC——
1412Mirai Bio——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.